Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

1.

A Possible Mechanistic Link Between the CYP2C19 Genotype, the Methadone Metabolite Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidene (EDDP), and Methadone-Induced Corrected QT Interval Prolongation in a Pilot Study.

Carlquist JF, Moody DE, Knight S, Johnson EG, Fang WB, Huntinghouse JA, Rollo JS, Webster LR, Anderson JL.

Mol Diagn Ther. 2015 Apr 23. [Epub ahead of print]

PMID:
25903311
2.

Methadone therapy in underserved urban community: QTc prolongation and life-threatening ventricular arrhythmias.

Chowdhury M, Wong J, Cheng A, Khilkin M, Palma E.

Cardiovasc Ther. 2015 Mar 31. doi: 10.1111/1755-5922.12120. [Epub ahead of print]

PMID:
25825202
3.

Methadone induced torsades de pointes and ventricular fibrillation: A case review.

Khalesi S, Shemirani H, Dehghani-Tafti F.

ARYA Atheroscler. 2014 Nov;10(6):339-42.

4.

The QTc Effect of Low-Dose Methadone for Chronic Pain: A Prospective Pilot Study.

Grodofsky S, Edson E, Huang S, Speck RM, Hatchimonji J, Lacy K, Farrar JT, Ashburn MA.

Pain Med. 2015 Feb 3. doi: 10.1111/pme.12658. [Epub ahead of print]

PMID:
25644980
5.

Extreme doses of intravenous methadone for severe pain in two children with cancer.

Rasmussen VF, Lundberg V, Jespersen TW, Hasle H.

Pediatr Blood Cancer. 2015 Jun;62(6):1087-90. doi: 10.1002/pbc.25392. Epub 2015 Jan 13.

PMID:
25641929
6.

Safety and tolerability of slow-release oral morphine versus methadone in the treatment of opioid dependence.

Hämmig R, Köhler W, Bonorden-Kleij K, Weber B, Lebentrau K, Berthel T, Babic-Hohnjec L, Vollmert C, Höpner D, Gholami N, Verthein U, Haasen C, Reimer J, Ruckes C.

J Subst Abuse Treat. 2014 Oct;47(4):275-81. doi: 10.1016/j.jsat.2014.05.012. Epub 2014 Jun 10.

PMID:
25064422
7.

KCNH2 polymorphism and methadone dosage interact to enhance QT duration.

Hajj A, Ksouda K, Peoc'h K, Curis E, Messali A, Deveaux LL, Bloch V, Prince N, Mouly S, Scherrmann JM, Lépine JP, Laplanche JL, Drici MD, Vorspan F.

Drug Alcohol Depend. 2014 Aug 1;141:34-8. doi: 10.1016/j.drugalcdep.2014.04.027. Epub 2014 May 14.

PMID:
24875677
8.

The correlation between prolonged corrected QT interval with the frequency of respiratory arrest, endotracheal intubation, and mortality in acute methadone overdose.

Farsi D, Mirafzal A, Hassanian-Moghaddam H, Azizi Z, Jamshidnejad N, Zehtabchi S.

Cardiovasc Toxicol. 2014 Dec;14(4):358-67. doi: 10.1007/s12012-014-9259-x.

PMID:
24811951
11.

Methadone safety: a clinical practice guideline from the American Pain Society and College on Problems of Drug Dependence, in collaboration with the Heart Rhythm Society.

Chou R, Cruciani RA, Fiellin DA, Compton P, Farrar JT, Haigney MC, Inturrisi C, Knight JR, Otis-Green S, Marcus SM, Mehta D, Meyer MC, Portenoy R, Savage S, Strain E, Walsh S, Zeltzer L; American Pain Society; Heart Rhythm Society.

J Pain. 2014 Apr;15(4):321-37. doi: 10.1016/j.jpain.2014.01.494.

PMID:
24685458
12.

Methadone, QTc prolongation and torsades de pointes: Current concepts, management and a hidden twist in the tale?

Mujtaba S, Romero J, Taub CC.

J Cardiovasc Dis Res. 2013 Dec;4(4):229-35. doi: 10.1016/j.jcdr.2013.10.001. Epub 2013 Nov 16. Review.

13.

Methadone for pain and the risk of adverse cardiac outcomes.

Price LC, Wobeter B, Delate T, Kurz D, Shanahan R.

J Pain Symptom Manage. 2014 Sep;48(3):333-42.e1. doi: 10.1016/j.jpainsymman.2013.09.021. Epub 2014 Jan 28.

PMID:
24480532
14.

Pattern of QTc prolongation in Methadone Maintenance Therapy (MMT) subjects receiving different methadone dosages: A prospective cohort study.

Mohamad N, Abdul Jalal MI, Hassan A, Abdulkarim Ibrahim M, Salehuddin R, Abu Bakar NH.

Pak J Med Sci. 2013 Sep;29(5):1132-6.

15.

Patterns of care and side effects for patients prescribed methadone for treatment of chronic pain.

Macey TA, Weimer MB, Grimaldi EM, Dobscha SK, Morasco BJ.

J Opioid Manag. 2013 Sep-Oct;9(5):325-33. doi: 10.5055/jom.2013.0175.

16.

Prolonged QT interval by methadone: relevance for daily practice? A prospective study in patients with cancer and noncancer pain.

van den Beuken-van Everdingen MH, Geurts JW, Patijn J.

J Opioid Manag. 2013 Jul-Aug;9(4):263-7. doi: 10.5055/jom.2013.0167.

PMID:
24353019
17.

An ECG-based cardiac safety initiative is well received by opioid treatment program staff: results from a qualitative assessment.

Katz DF, Albright K, Krantz MJ.

J Addict Dis. 2013;32(4):387-92. doi: 10.1080/10550887.2013.849975.

PMID:
24325772
18.

Effect of amphetamine on corrected-QT interval change during methadone maintenance treatment in Taiwan: a prospective cohort study.

Lin NC, Huang CL, Chen CY, Lin TY, Wang HY, Lu YH, Chen LM, Chen VC, Gossop M.

Drug Alcohol Rev. 2014 Mar;33(2):194-201. doi: 10.1111/dar.12099. Epub 2013 Dec 10.

PMID:
24320220
19.

High dose droperidol and QT prolongation: analysis of continuous 12-lead recordings.

Calver L, Isbister GK.

Br J Clin Pharmacol. 2014 May;77(5):880-6. doi: 10.1111/bcp.12272.

20.

Methadone, QTc interval prolongation and torsade de pointes: Case reports offer the best understanding of this problem.

Vieweg WV, Hasnain M, Howland RH, Clausen T, Koneru JN, Kogut C, Crouse EL, Hancox JC, Fernandez A, Pandurangi AK.

Ther Adv Psychopharmacol. 2013 Aug;3(4):219-32. doi: 10.1177/2045125312469982.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk